| Issue Date | Title | Author(s) |
| 2012 | Entecavir maleate versus Entecavir in Chinese patients with HBeAg-Positive Chronic Hepatitis B: Results at 48 and 96 weeks of a Randomized Double-blind Multicenter Clinical Trial | Yu, Yanyan; Xu, Jinghang; Tang, Hong; Zhang, Dazhi; Mao, Qing; Li, Jun; Xu, Zhongnan; Zhang, Xiquan; Dai, Jun; Si, Chongwen |
| 2014 | High Response Rate and Good Tolerability of Genotype 6 Chronic Hepatitis C Patients to Pegylated Interferon alfa combining Ribavirin in China | Wei, Lai; Gao, ZhiLiang; Mao, Qing; Zhang, Dazhi; Jiang, Jianning; Gong, Guozhong; Yin, Zhibiao; Xie, Qing; Sun, Jian; Rao, Huiying; Feng, Bo; Yang, Ruifeng; Zhang, Haiying |
| 2013 | IL28B genotype and IFNL4 ss469415590 Delta G variant are both associated with response to pegylated IFN-alpha and ribavirin therapy in Chinese patients with chronic hepatitis C | Rao, Huiying; Wei, Lai; Yang, Ruifeng; Chen, Xin-Yue; Jia, Shang; Gao, ZhiLiang; Xie, Qing; Dou, Xiaoguang; Xu, Xiaoyuan; Gong, Guozhong; Chen, Guofeng; Li, Jun; Zhang, Dazhi; Niu, Junqi; Chen, Hong; Feng, Yinong; Hou, Jinlin; You, Hong; Wu, Yun; Zhao, Peili |
| Nov-2020 | LONG-TERM FOLLOW-UP OF PEGINTERFERON ALFA TREATMENT OF HBEAG-POSITIVE CHRONIC HEPATITIS B PATIENTS IN PHASE III STUDY OF PEGINTERFERON ALFA-2b (40kD, Y SHAPE) (PEGBERON): A 4-YEAR FOLLOW-UP REPORT | Wang, Guiqiang; Hou, Fengqin; Zhang, Min; Shang, Jia; Pan, Chen; Lv, Hui; Zhang, Mingxiang; Peng, Yanzhong; Xie, Qing; Wang, Maorong; Zhang, Dazhi; Chen, Yongping; Mao, Qianguo; Liu, Jiajun; Peng, Jie; Mao, Qing; Yang, Yongfeng; Yin, Chibiao; Han, Tao; Cheng, Na; Zhen, Zhen; Zhang, Jiming; Tan, Deming; Chen, Liang; Meng, Qinghua; Wang, Hao; Chen, Chengwei; Li, Baosen; Chen, Jun; Yin, Yalin; Sun, Li |
| 2017 | Long-term follow-up of peginterferon alpha treatment of HBeAg-positive chronic hepatitis B patients in phase III study of peginterferon alpha-2b (40kD, Y Shape) (Pegberon) | Hou, Fengqin; Shang, Jia; Zhang, Mingxiang; Pan, Chen; Peng, Yan-zhong; Chen, Shijun; Zhang, Dazhi; Zhao, Wei; Mao, Qian-guo; Mao, Qing; Chen, Yongping; Wang, Maorong; Yin, Chibiao; Peng, Jie; Wang, Hao; Meng, Qinghua; Tan, Deming; Sun, Li; Wang, Guiqiang |
| 2017 | Long-term follow-up of peginterferon alpha treatment of HBeAg-positive chronic hepatitis B patients in phase III study of peginterferon alpha-2b (40kD, Y Shape) (Pegberon) | Hou, Fengqin; Shang, Jia; Zhang, Mingxiang; Pan, Chen; Peng, Yan-zhong; Chen, Shijun; Zhang, Dazhi; Zhao, Wei; Mao, Qian-guo; Mao, Qing; Chen, Yongping; Wang, Maorong; Yin, Chibiao; Peng, Jie; Wang, Hao; Meng, Qinghua; Tan, Deming; Sun, Li; Wang, Guiqiang |
| 2018 | Long-Term Follow-up of Peginterferon alpha-2b (40kD, Y Shape) (Pegberon) Treatment of Hbeag-Positive Chronic Hepatitis B Patients in Phase III Study | Wang, Guiqiang; Hou, Fengqin; Zhang, Mingxiang; Zhang, Dazhi; Peng, Yanzhong; Shang, Jia; Chen, Shijun; Gong, Guozhong; Chen, Yongping; Wang, Maorong; Pan, Chen; Xie, Qing; Zhao, Wei; Liu, Jiajun; Peng, Jie; Mao, Qing; Yin, Chibiao; Zhang, Jiming; Zhen, Zhen; Chen, Liang; Tan, Deming; Wang, Hao; Mao, Qianguo; Meng, Qinghua; Chen, Chengwei; Sun, Li |
| 2018 | Long-Term Follow-up of Peginterferon alpha-2b (40kD, Y Shape) (Pegberon) Treatment of Hbeag-Positive Chronic Hepatitis B Patients in Phase III Study | Wang, Guiqiang; Hou, Fengqin; Zhang, Mingxiang; Zhang, Dazhi; Peng, Yanzhong; Shang, Jia; Chen, Shijun; Gong, Guozhong; Chen, Yongping; Wang, Maorong; Pan, Chen; Xie, Qing; Zhao, Wei; Liu, Jiajun; Peng, Jie; Mao, Qing; Yin, Chibiao; Zhang, Jiming; Zhen, Zhen; Chen, Liang; Tan, Deming; Wang, Hao; Mao, Qianguo; Meng, Qinghua; Chen, Chengwei; Sun, Li |
| 2011 | A PROSPECTIVE, RANDOMIZED, OPEN LABEL, MULTI-CENTER STUDY ON RGT TREATMENT FOR CHINESE NAiVE CHC PATIENTS: AN INTERIM ANALYSIS | Chen, Xin-Yue; Rao, Huiying; Wei, Lai; Wu, Yun; You, Hong; Niu, Junqi; Feng, Yinong; Li, Jun; Zhang, Dazhi; Chen, Hong; Chen, Guofeng; Jia, Shang; Hou, Jinlin; Zhao, Peili; Xu, Xiaoyuan; Gao, Zhi-liang; Gong, Guozhong; Xie, Qing; Dou, Xiaoguang; Jiang, Michael |
| 2016 | A randomized, double-blind, double-dummy, controlled, multicenter study of entecavir maleate versus entecavir for treatment of Chinese chronic hepatitis B predominantly genotype B or C: results at week 144 | Xu, Jinghang; Yu, Yanyan; Si, Chongwen; Zeng, Zheng; Li, Jun; Mao, Qing; Zhang, Dazhi; Tang, Hong; Sheng, Ji-Fang; Chen, Xinyue; Ning, Qin; Shi, Guangfeng; Xie, Qing; Zhang, Xiquan; Dai, Jun; Xu, Zhongnan |
| 2016 | A randomized, double-blind, double-dummy, controlled, multicenter study of entecavir maleate versus entecavir for treatment of Chinese chronic hepatitis B predominantly genotype B or C: results at week 144 | Xu, Jinghang; Yu, Yanyan; Si, Chongwen; Zeng, Zheng; Li, Jun; Mao, Qing; Zhang, Dazhi; Tang, Hong; Sheng, Ji-Fang; Chen, Xinyue; Ning, Qin; Shi, Guangfeng; Xie, Qing; Zhang, Xiquan; Dai, Jun; Xu, Zhongnan |
| 2017 | Serum hepatitis B core antibody as a biomarker of hepatic inflammation in chronic hepatitis B patients with normal alanine aminotransferase | Zhou, Jiyuan; Song, Liuwei; Zhao, Hong; Yan, Linlin; Ma, Anlin; Xie, Shibin; Zhang, Xuqing; Zhang, Dazhi; Xie, Qing; Zhang, Guo; Shang, Jia; Cheng, Jun; Zhao, Weifeng; Zou, Zhiqiang; Zhang, Mingxiang; Xia, Ningshao; Wang, Guiqiang |
| 2019 | Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China | Sun, Jian; Ding, Huiguo; Chen, Guofeng; Wang, Guiqiang; Wei, Lai; Zhang, Jiming; Xie, Qing; Wan, Mobin; Tang, Hong; Chen, Shijun; Gao, Zhiliang; Wang, Yuming; Zhang, Dazhi; Huang, Wenxiang; Sheng, Jifang; Ning, Qin; Yang, Dongliang; Lu, Jian; Pan, Chen; Yang, Yuxiu; Wang, Jue; Sun, Chuanzhen; Wang, Qixin; Hou, Jinlin |
